Member Info for stephen11

So we can presume they’ll be around the end November again this year.

The figures won’t lie - good (hopefully), or bad.

Good man Popeye - hope RUA continues growing and makes you some £.

I’m big into KOD at the moment - waiting on a licence transfer, plant ready to produce from Jan 2025, and fully funded from the Hainan group.

Two cruises 🚢 booked next year, but no more this year, unfortunately.

Hoping GDR comes good aswell.

What's your exit price now then Popeye62?

Thanks rbsO8 - good info sharing.

I take it that, for quality control purposes GDR test a certain percentages of the manufactured kits - and this document records this information.

Is there any way we can get the gross number of kits produced during this manufacturing run - maybe i'm wrong but I do recall such manufacturing batch info being shared on this portal before.

All input on this appreciated!

GLA.

Stephen11.

Agreed - i've been in for over 4 years - whats another 4-6 weeks amongst friends.

In life we all have to play with the cards we are dealt.

Gino is the CEO and non of us have the power to change that.

And all this talk of him not having previous experience as a CEO…all CEOs had to start somewhere?…they just don’t appear ready to be dropped into the hot seat 💺.

Absolutely, probably a wide spectrum of average share prices - 2p, 4p, 5p, 10p, 50p, £1.00, £2.00 and everything in between.

Yes - I remember a poster called Punit who had an average of £2.00 - I kid you not - are you still out there Punit?

On HL.

I don’t know what’s going on, but I like it 😊

Maybe the tea ☕️ lady has been talking - it’s always the foot soldiers who are the last to hear of good or bad news with GDR.

A NICE 😊 sales RNS would do my old heart ♥️ good 😊.

Well - time will tell Allguessing

Ps...apologies for my poor spelling and grammar in previous message - the curse of working between 3 screens.

I would dare to suggest that the "POCT Innovators Expo in London" is as tad more specialist that the village fair, and the kind on place GDR should be.

Maybe they are lobbying government - i don't know, that's part of my point - shareholder communication from GDR is very poor in general.

Now, i'm no fan of politicians in general and I have no love for either of the two main parties in government - let's get that point clear from the start.

However, the two Genedrive machines and associated tests appear to be compatible with Labours strategy for the NHS, as recently announced by Starmer.

For Example:

- Both tests provide speedy results onto computerised systems: answering the call for increased automation in the NHS and for all systems to move from analogue to digital

- The CYP2C19 test can reduce the time spent in hospital for Stroke patients, by preventing adverse drug reactions from Clipidogrel and by providing alternative medication in a speedy manner - helping prevent secondary stoke

- The MTRNR-1 test can save infants from lifelong hearing loss and the need for expensive cochlear implants

All this can save the NHS money and improve a patients quality of life.

Why aren't Genedrive shouting this all from the rooftops and speaking to those of influence in government and the NHS.

GLA.

Stephen11.

Ps...and why have we had no communication from the board, especially when 94% of shareholders answered the call by participating in the latest fundraise, preventing the company from a very precarious financial position?

Raised £6m in June 2024 2rein, so at a monthly cash burn of £400,000 - £450,000 GDR are funded to between June to Sept 2025.

Nice try at deramping, but cross check the facts next time please.

Thanks for sharing Eldi.

I'm not shooting the messenger, although I just hope that sales come fast to justify all these fancy new titles. Director of this and director of that....

I'd much prefer a tighter control of monthly cash-burn until we achieve a significant amount of commercial traction.

If promotions were linked to KPIs and results GDR shouldn't be promoting to many people, at present anyway.

GDR is funded to at least next June to Sept 2025.

We raised £6m and the monthly cash burn is between £400,000 - £450,000 per month, so 12 to 15 months from last month.

Additionally, R+D spend was said to be reducing as the stroke and hearing loss products are fully developed.

The other point I would make is that this company is largely owned by private investors - with a wide spectrum of average share prices.

Some new or long term holders might have an average of below 2p with the latter group averaging down at the last placing. Conversely others may have an average of 5p, 10p, 50p, £2.00, or anything in between.

The point I’m eluding to is that any low ball takeover bid could be easily batted away and out voted by shareholders.

I believe we are on the cusp of real commercial. Getting orders from an NHS trust takes time 🕰️, it’s not next day delivery like Amazon Prime, as some expect.

GLA.

Stephen11.

The lack of communication is indeed rather frustrating.

I am a big fan of the tests and the good they can do around the world, I’ll say that.

However, the board is showing a certain arrogance and contempt to the 94% of private investors who partook in the last fundraise, saving the company from a very precarious position.

I’m not wanting a daily or weekly update, but a message or interview outlining GDRs strategy for commercialisation would be appreciated.

I to have cascaded this message directly to GDR and Walbrook to no avail.

GLA.

Stephen11.

I opted for an Audi Q4 - full charge is around 300 miles. Its a nice motor and drives really well.

This will have to do until this shares reaches its full potential.

GLA.

stephen11.

Now, i'm no fan of politicians in general and i have no love for either of the two main parties in government - let's get that point clear from the start.

However, the two Genedrive machines and associated tests appear to be compatible with Labours strategy for the NHS, as announced by Starmer today.

For Example:

- Both tests provide speedy results onto computerised systems: answering the call for increased automation in the NHS and for all systems to move from analogue to digital

- The CYP2C19 test can reduce the time spent in hospital for Stroke patients, by preventing adverse drug reactions from Clipidogrel and by providing alternative medication in a speedy manner - helping prevent secondary stoke

- The MTRNR-1 test can save infants from lifelong hearing loss and the need for expensive cochlear implants

All this can save the NHS money and improve a patients quality of life.

Why aren't Genedrive shouting this all from the rooftops and speaking to those of influence in government and the NHS.

GLA.

Stephen11.

Ps...and why have we had no communication from the board, especially when 94% of shareholders answered the call by participating in the latest fundraise, preventing the company from a very precarious financial position?